Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

Researchers Debate Ezetimibe (Vytorin) ENHANCE Trial -Part 1

Loading...

Sign in or sign up now!
1,147
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Apr 18, 2008

http://www.medpagetoday.com
Evan A. Stein, M.D., Ph.D., Metabolic and Atherosclerosis Research Center in Cincinnati

Allen J. Taylor, M.D., of the Uniformed Services University of the Health Sciences Walter Reed Army Medical Center in Washington

Controversy over the ENHANCE trial continued despite lengthy presentations at the American College of Cardiology meeting earlier this month. In this exclusive video report MedPage Today talks in-depth with two researchers about ezetimibe, LDL, and clinical implications of the trial.

Category:

Education

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (1)

Sign In or Sign Up now to post a comment!
  • I was so happy to find this series of three video discussions of the ENHANCE trial data. The topics discussed in this video series has very much elucidated the issues surrounding my questions of the Ezetimibe controversy and am so glad that Medpagetoday has posted this. Truly an excellent and helpful contribution to the fundamentals of the technical discussion.

Loading...

0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more